Tag - Food and Drug Administration

How to Reverse the Abortion Pill

June 20, 2017

Abortion, Baby, Children, Life, Prolife News

This therapy has a 60 to 70 percent success rate in reversing the effects of the abortion pill.

U.S. medication abortions have been on the rise since 2000, when the Food and Drug Administration approved mifepristone under President Bill Clinton.

According to the Guttmacher Institute, medication abortions have increased from 6 percent of all abortions in 2001 to 31 percent in 2014, despite the overall decline in the number of abortions in the U.S. during that same period. Full Article

In addition, medication abortions account for nearly half (45 percent) of all abortions committed prior to nine weeks gestation.

In 2016, the FDA under President Barack Obama expanded the timeframe for the use of mifepristone to 10 weeks gestation. That move put women’s health and safety at further risk, since the abortion pill regimen is less effective the further along the woman is and carries a higher risk of major adverse events.

For more information on the abortion pill reversal, visit www.abortionpillreversal.com or call (877) 558-0333.

Little Deivice to Sterilize Woman Causes Big Problems

December 21, 2016

admin@aimalive.com

Baby, Children, Family, Life, Medical, Prolife News, Sexuality

Women who used the (sterilization) device “Ensure” had 10 times as many operations to fix problems as women who had surgery instead.

The Essure boxed warning will alert patients and health professionals to adverse events associated with the device including the possibility for uterine perforation, chronic pain, serious allergic reactions, device migration into the abdominal or pelvic cavity, and the need for the device to be removed surgically if symptoms become unbearable. Full Article

While the FDA’s belated move is a step in the right direction, many want to see the device banned from the U.S. market altogether.

“The latest recommendations from the FDA do not go far enough,” Congressman Mike Fitzpatrick (PA–8) said in a released statement concerning the FDA’s approval of a new boxed warning for Essure, “a boxed warning and patient checklist highlight the severe risks of Essure—but they’re not legally enforceable requirements.”

Last year, Rep. Fitzpatrick introduced a bipartisan bill in Congress called the E-Free Act which would circumvent the FDA and ban the Essure device outright.

“Tens of thousands of women have been harmed by this unsafe medical device, including hundreds of fetal deaths,” Rep. Fitzpatrick said in his released statement.